Together, these data suggest that FGFR4 exhibits a pivotal functional impact on GBM aggressiveness, and that the FGF19/FGFR4 interaction should dominate the FGFR-related signaling in this FGFR4high GBM subgroup. This evidence concerns the gene FGF19 and glioblastoma.